Role of 68Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)

Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

Michael Hofmann, Helmut R. Maëcke, A. Börner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 541 citations

Medicine, Nuclear Medicine, Radiology +14

Functional imaging of neuroendocrine tumors with combined PET/CT using ⁶⁸Ga‐DOTATATE (DOTA‐<scp>D</scp>Phe¹,Tyr³‐octreotate) and ¹⁸F‐FDG

Irfan Kayani, Jamshed Bomanji, Ashley M. Groves et al. · Cancer · 2008 · 466 citations · Full text

Medicine, Oncology, Radiology +17

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 447 citations

Medicine, Nuclear Medicine, Radiology +16

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

Damian Wild, Jörg Schmitt, Mihaela Ginj et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 301 citations

Medicine, Endocrinology, Pharmacology +8

High management impact of Ga‐68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Michael S. Hofman, Grace Kong, Oliver Neels et al. · Journal of Medical Imaging and Radiation Oncology · 2012 · 252 citations · Full text

Medicine, Nuclear Medicine, Oncology +17